Skip to main
APGE
APGE logo

APGE Earnings Dates & Reports

APGE Most Recent Earnings

Report DateAug 11, 2025
Period EndingQ2 2025
Est. EPS-$1.03
Actual EPS-$1.13
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

APGE Earnings per Share (EPS) History

Signup for full access
Browse free

APGE Latest Earnings

The value each APGE share was expected to gain vs. the value each share gained.

APGE reported its most recent earnings on Aug 11, 2025 for Q2 2025, posting earnings per share (EPS) of -$1.13. This exceeded analysts' expectations of -$1.03 by 9.71%, marking a Miss.

For comparison, Apogee Therapeutics Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 11/11/2025, with analysts projecting an EPS of -$1.17.

APGE Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 12, 2025
-$1.17Next earnings call Nov. 11, 2025
Q2 2025Aug 11, 2025
-$1.03-$1.13+9.71%

APGE Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Apogee Therapeutics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 11, 2025

APGE Earnings FAQs

APGE last reported earnings on Aug 11, 2025 for Q2 2025, posting an EPS of -$1.13, which Miss the estimate of -$1.03 by 9.71%.

For Q2 2025, APGE reported an EPS of -$1.13, missing analysts' estimate of -$1.03 by 9.71%.

For Q2 2025, APGE Miss expectations with an actual EPS of -$1.13 vs. an estimated EPS of -$1.03.

Following the last earnings report on Aug 11, 2025, APGE's stock price moved — from — to —.

The next APGE earnings call is scheduled for Nov. 11, 2025, where executives will discuss financial results and outlook.

Apogee Therapeutics Inc (APGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.